Breast Health
Continuum of Care
Time is precious when it comes to effective detection, diagnosis and treatment of breast cancer. We strive to save you time at every step along the Breast Health Continuum of Care ensuring more women have more time in better health.
Quantra™ Technology
Higher breast density is known to increase a woman’s risk for breast cancer.1-2 The need for accurate, unbiased analysis is therefore critical. Powered by machine learning, Quantra software analyses the breast tissue texture and pattern in both 2D and tomosynthesis images and categorises the breasts into four composition risk categories.3
Screening & Diagnosis Solution
Explore our clinically proven,* integrated breast imaging and diagnostic solutions optimising your clinical pathway while enhancing a woman’s breast imaging experience. We offer the highest quality4 of imaging that enables confident detection with mammography technologies, and advanced ultrasound systems.
Breast Biopsy Solution
Our mission is to transform breast care with compassionate and effective solutions that maximise value, while minimising the negative impacts of interventional procedures. The best technologies should ease patient anxiety and help clinicians focus on what’s most important, providing the best possible care.
LOCalizer™ Wire-free Guidance System
The LOCalizer wire-free guidance system is designed to provide precision guidance for breast surgeons. Non-palpable breast lesions can be easily located using a miniature radiofrequency identification (RFID) Tag. Tag placement can be done >30 days prior to surgery.
BioZorb® 3D Bioabsorbable Marker
BioZorb is a three-dimensional (3D) implantable marker that consists of a spiral, bioabsorbable framework embedded with 6 permanent, titanium clips.
Under development, please contact us for future availability.
Faxitron® Trident® HD Specimen Radiography System
Have the markers been captured? Are the margins clear? And are targeted calcifications visible? Now you can have highly detailed imaging for rapid verification in the OR procedure room. The Faxitron Trident HD system’s sleek, modern and ergonomic design has a small footprint, and is easily manoeuvrable from room to room. Its imaging area is large enough to accommodate a large range of sample sizes.
Faxitron® Path Specimen Radiography System
The Faxitron Path Specimen Radiography System provides optimal imaging for large or thin sliced specimens, resulting in fewer re-cuts. The Faxitron Path system provides up to 6x (or 10x with Faxitron Path+ System) geometric magnification, which can locate very small calcifications in tissue samples to ensure accurate diagnoses.
Horizon® DXA System
Breast cancer and associated treatments have a high impact on patients. The Horizon DXA system enables a close monitoring of bone mineral density and assessments of vertebral fracture and fat/lean distribution, thereby enriching the quality of your diagnosis during and after cancer treatment.
Decades of Continuous Innovation
Our pioneering integrated portfolio helps you deliver maximum clinical confidence and workflow efficiency across the patient pathway. We harness innovative technologies to advance earlier diagnosis and support a compassionate, minimally invasive approach to patient care. Our technology is powered by 30 years of Hologic’s expertise in delivering smart solutions to complex diagnostic and treatment needs.
Our Expert Team is Here to Help
We enable you to deliver the very best patient services through a comprehensive set of educational resources that support optimum clinical practice and patient care, as well as providing support for building business cases. Our specialist team is on hand to help.
Visit Our Virtual Hospital
Browse our portfolio of Breast Health solutions in 3D. See how you can unlock the advantage of time across the entire Breast Continuum of Care.
*Supporting evidence can be provided upon request.
1. Rafferty EA, Durand MA, Conant EF, et al. Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Non-dense Breasts. JAMA. 2016 Apr 26;315(16):1784-6.
2. Dense breast higher risk factor. Available at: https://www.cancer.gov/types/breast/breast-changes/dense-breasts#:~:text=Dense%20breasts%20are%20not%20considered,than%20women%20with%20fatty%20breasts. (Accessed Nov 2022)
3. Similar to ACR BI-RADS Atlas 5th Edition. 2013. Available at: https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Bi-Rads (Accessed Nov 2022).
4. Compared to other standard models. Rocha Garcia, A.M., Mera Fernandez, D. Breast tomosynthesis: State of the art. Radiologia. 2019;61(4):274-285.
Featured Products
2797
Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium
Notified Body number wherever applicable
EC Representative Information wherever applicable